Cai Haijian, Zheng Dandan, Yao Yizhu, Yang Lehe, Huang Xiaoying, Wang Liangxing
The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Front Cell Dev Biol. 2022 Apr 6;10:847761. doi: 10.3389/fcell.2022.847761. eCollection 2022.
Embryonic lethal abnormal vision-like (ELAVL) proteins are RNA binding proteins that were originally discovered as indispensable regulators of the development and functioning of the nervous system. Subsequent studies have shown that ELAVL proteins not only exist in the nervous system, but also have regulatory effects in other tissues. ELAVL proteins have attracted attention as potential therapeutic targets because they stabilize multiple mRNAs by binding within the 3'-untranslated region and thus promote the development of tumors, including hepatocellular carcinoma, pancreatic cancer, ovarian cancer, breast cancer, colorectal carcinoma and lung cancer. Previous studies have focused on these important relationships with downstream mRNAs, but emerging studies suggest that ELAVL proteins also interact with non-coding RNAs. In this review, we will summarize the relationship of the ELAVL protein family with mRNA and non-coding RNA and the roles of ELAVL protein family members in a variety of physiological and pathological processes.
胚胎致死性异常视觉样(ELAVL)蛋白是RNA结合蛋白,最初被发现是神经系统发育和功能不可或缺的调节因子。随后的研究表明,ELAVL蛋白不仅存在于神经系统中,而且在其他组织中也具有调节作用。ELAVL蛋白作为潜在的治疗靶点受到关注,因为它们通过在3'非翻译区内结合来稳定多种mRNA,从而促进包括肝细胞癌、胰腺癌、卵巢癌、乳腺癌、结直肠癌和肺癌在内的肿瘤发展。以往的研究集中在这些与下游mRNA的重要关系上,但新出现的研究表明,ELAVL蛋白也与非编码RNA相互作用。在这篇综述中,我们将总结ELAVL蛋白家族与mRNA和非编码RNA的关系,以及ELAVL蛋白家族成员在各种生理和病理过程中的作用。